Key Takeaways Oral GLP-1 receptor agonists are now the primary areas of innovation with the promise of giving patients a more practical alternative to injectable obesity therapies and, hopefully, higher rates of long-term adherence growing from $1.95 billion revenue in 2025 to account for more than 48% of the market by 2035
The global coronavirus pandemic has impacted the entire population of the world in one way or another, and fears of infection have led to massive lockdowns, mask wearing and a massive push by pharmaceutical companies to inject an experimental treatment into the arm of every human on earth
Molecular weight (MW): 5358.05
When skin is under stress (weather, over-exfoliation, lack of sleep, life), it can start looking thinner, duller, and less firm
Zn has an important role as a constituent of over 300 enzymes from all six enzyme classes
Therefore, continuous testing and calibration are essential to ensure accuracy in aPTT results